[ Price : $8.95]
FDA warns New Delhi, India-based Unexo Lifesciences about CGMP and other violations in its production of finished drugs.[ Price : $8.95]
FDA warns Italys Originitalia about CGMP violations in its production of finished drugs.[ Price : $8.95]
Novo Nordisk petitions FDA to take specific steps to follow through on the companys nomination of semaglutide (Rybelsus, Ozempic, ...[ Price : $8.95]
FDA cautions Silliker contract testing laboratory about CGMP violations at its Gainesville, FL, facility.[ Price : $8.95]
FDA warns the Colgate-Palmolive Toms of Maine unit about CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Frequently Asked Questions Developing Potential Cellular a...[ Price : $8.95]
Federal Register notice: FDA determines that GlaxoSmithKlines Jesduvroq (daprodustat) tablets were not withdrawn due to safety or ...[ Price : $8.95]
FDA asks members of its Digital Health Advisory Committee to spend two days discussing agency questions about its role in regulati...